Bio ProtocolBIO#424C- rating
Financial layer for DeSci
$0.02269
↓ -$0.001144 · -4.80% (24H)
Price chart
LiveNo data
Market data
Market cap$48.68M
Fully diluted valuation$75.34M
24H volume$11.53M
7D volume--
Circulating supply2,145,029,070.25
Max supply3.32B
Mined ratio64.61%
Next halving--
Market cap rank#424
Market share0.00%
All-time high$0.889
All-time low$0.0159
Price change (multiple periods)
1H+1.48%
24H-4.80%
7D-6.36%
14D-12.19%
30D-22.72%
90D-15.43%
YTD-43.50%
1Y-81.57%
04
Exchange distribution
1 | BIO/KRWBIO / KRW | $0.04709 | $6M | 28.75% | |
2 | BIO/USDTBIO / USDT | $0.02673 | $3.57M | 17.14% | |
3 | BIO/TRYBIO / TRY | $0.02537 | $1.79M | 8.57% | |
4 | BIO/USDTBIO / USDT | $0.0264 | $1.74M | 8.33% | |
5 | BIO/USDTBIO / USDT | $0.02276 | $975.54K | 4.68% | |
6 | BIO/USDTBIO / USDT | $0.04738 | $719.4K | 3.45% | |
7 | BIO/USDTBIO / USDT | $0.02258 | $574K | 2.75% | |
8 | BIO/USDTBIO / USDT | $0.02694 | $467.07K | 2.24% | |
9 | BIO/USDTBIO / USDT | $0.02385 | $403.09K | 1.93% | |
10 | BIO/TRYBIO / TRY | $0.02278 | $393.31K | 1.89% | |
11 | BIO/USDTBIO / USDT | $0.0266 | $388.64K | 1.86% | |
12 | BIO/USDTBIO / USDT | $0.02567 | $322.77K | 1.55% | |
13 | BIO/USDTBIO / USDT | $0.02608 | $262.06K | 1.26% | |
14 | BIO/USDTBIO / USDT | $0.02262 | $252.9K | 1.21% | |
15 | BIO/USDTBIO / USDT | $0.02538 | $235.37K | 1.13% | |
16 | BIO/USDTBIO / USDT | $0.02561 | $198.75K | 0.95% | |
17 | BIO/WETHBIO / WETH | $0.02281 | $164.74K | 0.79% | |
18 | BIO/TRYBIO / TRY | $0.02679 | $158.41K | 0.76% | |
19 | BIO/USDTBIO / USDT | $0.02638 | $153.46K | 0.74% | |
20 | BIO/USDBIO / USD | $0.02594 | $133.65K | 0.64% |
AI investment view
Based on historical content analysisWOOFUN Rating
C-
Overall score 41.8 / 100
Bio Protocol has an overall rating C-f C (total score 43.42), ranking high in market ecosystem, team governance, and economic model across six dimensions. The main point of deduction is safety compliance (0 points)—mainly affected by regulatory compliance (0 points), multiple-entry ratio (0 points), and other sub-items. Rating Team Conclusion: "Bio Protocol has relative advantages in market ecosystem, team governance, and economic model, but current shortcomings are focused on security and compliance." " It is recommended to observe small positions and wait for key sub-sectors to improve before increasing allocation weighting.
View Full Rating ReportRoadmap37.5 / 100F
Team74.6 / 100C
Market76.2 / 100C
Tokenomics44.5 / 100F
Security0 / 100F
Peer comparison
BINANCE-SMART-CHAIN peer assets| Metric | Bio ProtocolThis coin | BNBBNB | Gram (prev. Toncoin)GRAM | ChainlinkLINK |
|---|---|---|---|---|
| 当前价格 | $0.02269 | $572.23 | $1.41 | $8.45 |
| 市值 | $48.68M | $76.2B | $3.87B | $6.32B |
| 市值排名 | #424 | #4 | #25 | #18 |
| 24H 涨跌 | -4.80% | +1.23% | -2.63% | +1.89% |
| 7D 涨跌 | -6.36% | +0.23% | -- | +1.00% |
| 共识机制 | -- | PoSA | PoS | -- |
| 最大供应 | 3.32B | 200M | No cap | 1B |
| WOOFUN 评级 | C- (41.77) | D (31.78) | D- (23.63) | D+ (37.55) |
| ETF 状态 | -- | -- | -- | -- |
News Updates
Live sync
Loading...
Comments
No comments yet.